ArticlePharmaceuticals (Basel, Switzerland)2021

Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma.

Chuanhe Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.